Answers are grounded in this paper and cite their sources.
Although cervical cancer is the most common malignancy of the gynecologic system, very few tumor markers have been specially prepared for this disease. This article reviews some of the current investigations of those markers, particularly describing TA-4, a tumor antigen of cervical squamous cell carcinoma, which has currently been widely used in clinical practice.
No takes yet. Share an insight, caveat, or question.
Hiroshi Kato (1987) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: